北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 肾脏内科  > 期刊论文
学科主题: 临床医学
题名:
Tacrolimus Combined With Corticosteroids in Treatment of Nephrotic Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Trial
作者: Chen, Min1; Li, Hang2; Li, Xia-Yu3; Lu, Fu-Ming4; Ni, Zhao-Hui5; Xu, Fei-Fei6; Li, Xue-Wang2; Chen, Jiang-Hua3; Wang, Hai-Yan1; Chinese Nephropathy Membranous Stu1
关键词: Idiopathic membranous nephropathy, Nephrotic syndrome ; Tacrolimus
刊名: AMERICAN JOURNAL OF THE MEDICAL SCIENCES
发表日期: 2010-03-01
DOI: 10.1097/MAJ.0b013e3181ca3a7d
卷: 339, 期:3, 页:233-238
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal
研究领域[WOS]: General & Internal Medicine
关键词[WOS]: METHYLPREDNISOLONE PLUS CHLORAMBUCIL ; CYCLOSPORINE-A ; CYCLOPHOSPHAMIDE ; DISEASE ; NEPHRITIS ; REMISSION ; STEROIDS ; THERAPY ; RISK
英文摘要:

Background: Idiopathic membranous nephropathy (IMN), a common cause of nephrotic syndrome in adults, is usually treated with corticosteroids in combination with cyclophosphamide or cyclosporine. A recent placebo-controlled study suggested that tacrolimus monotherapy was effective in IMN. However, the effectiveness of tacrolimus versus classic regimen and its potential nephrotoxicity remain inconclusive. This study evaluated the efficacy and safety of tacrolimus plus prednisone in patients with nephrotic IMN. Methods: Seventy-three patients with nephrotic IMN were recruited in this multicenter randomized controlled trial, 39 receiving tacrolimus and prednisone, while 34 receiving cyclophosphamide and prednisone. Tacrolimus was given at 0.1 mg/kg/d initially and adjusted to a blood trough level at 5 to 10 ng/mL for 6 months and then reduced to 2 to 5 ng/mL in the subsequent 3 months. Results: Intention-to-treat analysis suggested that the remission rate at the end of the sixth month was significantly higher in tacrolimus group than that in cyclophosphamide group (85% versus 65%, P < 0.05). The decrease of proteinuria was significantly greater in tacrolimus group. At the end of the 12th month, the remission rates were comparable between these 2 groups. Patients treated with tacrolimus were more likely to develop glucose intolerance (or diabetes mellitus), infection, and hypertension. No obvious nephrotoxicity of calcineurin inhibitor was found in repeat renal biopsy. Conclusions: Tacrolimus plus corticosteroids is an alternative therapeutic regimen for nephrotic IMN. The short-term efficacy might be better than cyclophosphamide plus prednisone.

语种: 英语
WOS记录号: WOS:000275419000008
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/50938
Appears in Collections:北京大学第一临床医学院_肾脏内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Dept Nephrol, Beijing 100034, Peoples R China
2.Beijing Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China
3.Zhejiang Univ, Coll Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China
4.Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China
5.Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Renal, Shanghai 200030, Peoples R China
6.Wenzhou Med Coll, Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China

Recommended Citation:
Chen, Min,Li, Hang,Li, Xia-Yu,et al. Tacrolimus Combined With Corticosteroids in Treatment of Nephrotic Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Trial[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES,2010,339(3):233-238.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Chen, Min]'s Articles
[Li, Hang]'s Articles
[Li, Xia-Yu]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Chen, Min]‘s Articles
[Li, Hang]‘s Articles
[Li, Xia-Yu]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace